A low platelet count can occasionally be a tube-related measurement error rather than a problem inside your body. Here is how EDTA-related pseudothrombocytopenia is identified before anyone labels you with thrombocytopenia.
- Pseudothrombocytopenia is a falsely low platelet count caused by platelets clumping after collection, most often in an EDTA tube.
- Kiwango cha kawaida cha chembe sahani for most non-pregnant adults is approximately 150-450 × 10⁹/L, although laboratories set their own intervals.
- Platelet clumps on smear can make an automated analyzer undercount platelets because a cluster is not measured as separate cells.
- Citrate redraw often resolves EDTA platelet clumping; laboratories commonly apply a 1.1 dilution correction to a citrate platelet count.
- No bleeding symptoms plus an unexpectedly isolated low platelet count should prompt a smear review before treatment or urgent referral decisions.
- True thrombocytopenia can coexist with EDTA platelet clumping, so a normal citrate result is reassuring but must fit the clinical picture.
- Tathmini ya haraka is still needed for uncontrolled bleeding, new widespread petechiae, severe headache, confusion, or a platelet count below 10 × 10⁹/L.
What EDTA platelet clumping actually means
EDTA platelet clumping is an in-vitro laboratory artifact in which platelets stick together in the collection tube, causing a spuriously low automated platelet count. It does not by itself mean that platelets are being destroyed in the body, and it usually does not create a bleeding risk.
EDTA is the lavender-top tube additive used for most full blood counts because it binds calcium and prevents coagulation. In a small subset of people, calcium removal exposes platelet surface targets that allow naturally occurring antibodies to bridge platelets together. The analyzer may count a platelet cluster as one large particle, a white-cell-sized event, or nothing at all; see our overview of kile CBC inachojumuisha.
In my clinical work, the classic report is a platelet count of 48 × 10⁹/L in someone who feels entirely well, has no bruising, and has a normal hemoglobin and white-cell count. That discrepancy is not proof, but it is the moment to pause. Kantesti is an Mchambuzi wa mtihani wa damu wa AI that flags an isolated low platelet count alongside laboratory comments such as platelet aggregates, rather than treating the number as a diagnosis.
EDTA-dependent pseudothrombocytopenia is estimated in roughly 0.03-0.27% of routine outpatient samples, with higher rates among samples already referred for low platelet counts. Lippi and colleagues describe it as a clinically harmless but potentially consequential pre-analytical phenomenon because it can trigger unnecessary admissions, platelet transfusions, or steroid treatment (Lippi et al., 2012).
How platelet analyzers can undercount clumped samples
Automated platelet counts are reliable for dispersed platelets, but clusters fall outside the size and signal patterns the analyzer expects. A count can therefore fall from a genuine 220 × 10⁹/L to an apparent 40 × 10⁹/L without any biological platelet loss.
Impedance analyzers classify particles mainly by volume, while optical systems add light-scatter information. A platelet is usually about 2-3 micrometres across, but a clump can overlap with the red-cell fragment or leukocyte region. This is why a platelet histogram may be abnormal and why a laboratory may append “platelet clumps present” or “count unreliable.”
The analyzer's platelet flag is a prompt for human review, not a final diagnosis. A manual estimate from a well-made peripheral smear can be more useful than repeating the same EDTA tube, especially if the sample sat for 2 hours before analysis. For practical thresholds around procedures, our guide to platelet counts before dental extraction explains why a verified result matters.
Large platelets create a different, sometimes overlapping problem. Very large individual platelets may be missed by impedance methods even without visible clumps, often raising the mean platelet volume (MPV). A high MPV is not interchangeable with pseudothrombocytopenia; our review of large platelet causes separates these two findings.
What platelet clumps on a smear look like
Platelet clumps on smear appear as irregular grape-like groups of small purple granular elements, often concentrated at the feathered edge of the slide. Their location matters because counting only the central smear field can miss the very feature that explains the low result.
A trained morphologist checks the body and tail of the film under high power, not merely a single representative field. Platelet satellitism is a rarer EDTA-associated pattern in which platelets ring neutrophils like a rosette; it can also lower the reported platelet count. Both findings are sample phenomena, though satellitism and broad aggregates may occasionally occur together.
One useful detail is that EDTA clumping often progresses with time. A sample measured 10 minutes after collection may show 118 × 10⁹/L, then 42 × 10⁹/L at 90 minutes as more aggregates form. Laboratories vary in their workflow, so a normal initial count does not completely exclude this artifact if a later analyzer flag appears.
When I, Thomas Klein, MD, see a low count paired with a smear comment but no clinical bleeding, I ask for the actual smear interpretation before discussing immune thrombocytopenia. Similar microscopy-first reasoning is useful when a report mentions schistocytes on a blood film, although schistocytes require a much more urgent clinical context.
Why EDTA causes platelet clumps in some people
EDTA can trigger platelet clumping by chelating calcium and changing the shape of platelet membrane glycoproteins, allowing antibodies to bind and bridge neighboring platelets. This reaction occurs after collection, not because EDTA has harmed circulating platelets inside the body.
The best-supported mechanism involves antibodies, often IgG, IgM, or IgA, recognizing cryptic sites on the platelet GPIIb/IIIa complex after calcium-dependent structural change. The reaction is temperature and time dependent in some patients, which explains why a warmed sample can occasionally improve counting but is not a universal fix. It is a laboratory compatibility issue, not an allergy to EDTA.
Pseudothrombocytopenia can occur in healthy people and has been reported alongside autoimmune conditions, infections, malignancy, and pregnancy, but those associations do not establish causation in an individual. A positive ANA or a recent viral illness should not be used to explain the count until the artifact is excluded. Kantesti is an jukwaa la tafsiri ya vipimo vya damu la AI that reads a platelet result with its tube type, analyzer flags, and the rest of the CBC rather than in isolation.
The phenomenon may persist for years yet vary between draws. A patient can have a platelet count of 35 × 10⁹/L in EDTA on Monday and 230 × 10⁹/L in citrate the same morning, then show partial clumping again months later. Recording the preferred tube in the laboratory record can prevent repeated alarms.
How a citrate redraw confirms pseudothrombocytopenia
A platelet count that normalizes in a sodium citrate tube while the EDTA tube contains aggregates strongly supports EDTA-dependent pseudothrombocytopenia. The citrate count needs a dilution adjustment because the tube contains liquid anticoagulant.
Blue-top sodium citrate tubes are generally filled at a 9:1 blood-to-anticoagulant ratio. Many laboratories multiply the measured citrate platelet count by 1.1 to correct for dilution, though the local laboratory's validated method takes precedence. For example, a raw citrate result of 182 × 10⁹/L becomes about 200 × 10⁹/L after correction.
The redraw must be properly filled and gently mixed. An underfilled citrate tube changes the anticoagulant ratio and can create a different misleading result, which is one reason a laboratory scientist may reject an apparently simple repeat. Our explanation of blood test tube colors helps patients recognize why the tube choice is part of the test method.
Magnesium sulfate or acid-citrate-dextrose tubes can be useful when clumping continues in citrate, but this is usually a laboratory-directed decision. Nagler and colleagues documented a case in which recognition of EDTA-dependent pseudothrombocytopenia avoided an unnecessary diagnostic work-up after citrate testing showed an adequate count (Nagler et al., 2014).
When a citrate platelet count does not settle the question
A citrate redraw does not rule out true thrombocytopenia when the corrected count remains low, clumping occurs in more than one anticoagulant, or symptoms suggest bleeding. Some patients have multi-anticoagulant platelet aggregation, and some have a real low count alongside an artifact.
If the corrected citrate platelet count is 82 × 10⁹/L and the smear is free of clumps, that is genuine thrombocytopenia until proven otherwise. If EDTA is 25 × 10⁹/L and citrate is 86 × 10⁹/L with residual aggregates, both an artifact and a true reduction may be present. The clinical team should use the best verified estimate, not simply choose the more reassuring number.
Clotting in the specimen can also invalidate a CBC because platelets are consumed within the microclot. Unlike EDTA pseudothrombocytopenia, a partially clotted specimen may affect white cells and red-cell indices as well. Read our redraw guide after sample problems for the practical differences between collection artifacts.
Finger-prick samples are not automatically safer. Slow collection, squeezing, or delayed mixing can promote local aggregation and compromise a platelet count, particularly when the reported value is below 100 × 10⁹/L. Venous recollection with prompt processing is usually the cleaner confirmation route.
Platelet count ranges, bleeding risk, and the artifact trap
Most adult laboratories use a platelet count reference interval near 150-450 × 10⁹/L, but bleeding risk depends on the verified count, its cause, platelet function, and medications. A falsely low EDTA result must not be used alone to deny a procedure or prescribe treatment.
Spontaneous major bleeding becomes more likely as a true platelet count falls below about 10 × 10⁹/L, while many people with stable counts above 50 × 10⁹/L have little spontaneous bleeding. These are broad clinical guideposts, not permission to ignore symptoms. Anticoagulants, aspirin, liver disease, kidney failure, and platelet dysfunction can alter the risk at any number.
A platelet count of 90 × 10⁹/L deserves different handling in a well person with a normal citrate result than in someone with new melena and an elevated INR. That is why platelet count interpretation belongs beside coagulation testing; our aPTT and clotting test guide explains what a normal clotting screen can and cannot exclude.
Laboratories may use 140 × 10⁹/L rather than 150 × 10⁹/L as the lower reference limit, particularly with locally derived intervals. A reference interval describes 95% of a comparator population; it does not define a universal treatment threshold. This distinction saves a surprising amount of unnecessary worry.
CBC patterns that make an artifact more likely
An isolated unexpectedly low platelet count with normal hemoglobin, white cells, and a clumping comment is the CBC pattern most suggestive of pseudothrombocytopenia. This pattern is suggestive rather than diagnostic because early immune or drug-related thrombocytopenia may also be isolated.
True marrow disorders often alter more than one blood-cell line, although exceptions exist. Low platelets combined with falling hemoglobin, abnormal white cells, blasts, or persistent constitutional symptoms calls for prompt clinician review and often a formal film examination. Our article on the CBC pathway for blood disorders outlines why these clusters change the urgency.
The platelet-to-lymphocyte ratio can become meaningless when the denominator is valid but the platelet numerator is artificially depressed. A PLR of 60 calculated from an EDTA-clumped count should not be interpreted as an inflammatory or cardiovascular signal. This is a quiet but common secondary error in automated health reports; see our explanation of high PLR results.
Kantesti AI identifies discordance between a low platelet count and normal neighboring CBC measures, then directs the reader to verify sample comments. An Zana ya uchambuzi wa vipimo vya damu inayotumia AI should never convert a single unverified platelet value into a disease label. That clinical restraint matters more than speed.
Pregnancy, hospital care, and other high-stakes settings
EDTA platelet clumping can occur during pregnancy and hospital care, but it must never be assumed when true thrombocytopenia could change urgent management. Pregnancy-specific causes such as gestational thrombocytopenia, pre-eclampsia, HELLP syndrome, and immune thrombocytopenia require a verified count.
Platelet counts commonly drift downward in uncomplicated pregnancy, and some laboratories accept lower trimester-specific reference limits. A count below 100 × 10⁹/L is less typical for uncomplicated gestational thrombocytopenia and merits a careful clinical assessment, even if EDTA aggregates are seen. Our trimester-specific platelet reference guide in pregnancy gives context without replacing obstetric review.
In hospital, a sudden fall of more than 50% from baseline may raise questions about sepsis, drug exposure, heparin-induced thrombocytopenia, dilution, or device-related consumption. An EDTA artifact can mimic a dramatic decline, especially when a previous result came from a different laboratory method. Comparing a verified citrate result with the patient's baseline is often more useful than repeating a routine EDTA CBC.
Before an epidural, surgery, chemotherapy cycle, or platelet transfusion, ask whether the laboratory has confirmed the value on a smear or alternative anticoagulant. I have seen delays in care avoided by that one phone call. Conversely, active symptoms or an unstable patient should be assessed while confirmation is underway.
Medicines and diagnoses that should not be blamed too quickly
EDTA platelet clumping should be excluded before attributing an isolated low platelet count to a medicine, autoimmune disease, or immune thrombocytopenia. Stopping a valuable medication on the basis of an unverified count can cause avoidable harm.
Heparin, quinine-containing products, trimethoprim-sulfamethoxazole, valproate, linezolid, chemotherapy, and some immune therapies can cause real thrombocytopenia. The time relationship matters: a genuine drug-associated fall typically persists in a properly collected citrate sample and does not vanish when EDTA is replaced. A medication history should include injections, over-the-counter products, and herbal preparations.
Immune thrombocytopenia is a diagnosis of exclusion, not a laboratory flag. It can present with isolated platelets below 100 × 10⁹/L, but a clumped EDTA smear makes the initial count uninterpretable. Lippi et al. (2012) specifically caution that recognizing pseudothrombocytopenia prevents inappropriate therapies such as corticosteroids and splenectomy.
If a report appears to contradict your prior results, preserve the original PDF and note the collection date, tube comment, acute illness, and new medicines. Our guide to mabadiliko yenye maana kati ya vipimo vya damu explains why a numerical delta is not automatically a biological change.
What to ask your laboratory or clinician next
For an unexpected low platelet count, ask whether platelet clumps were seen, whether a peripheral smear was reviewed, and whether an alternative-anticoagulant count can be performed. Those three questions usually clarify the next step faster than searching for symptoms online.
A practical request is: “Could the laboratory review the blood film for platelet aggregates and, if needed, repeat the platelet count in citrate?” This is not demanding a particular diagnosis; it is asking that the measurement be validated. If the sample was collected elsewhere, the clinician may need to order a new draw rather than add testing to an old tube.
Uliza iliyorekebishwa citrate result and whether clumps persist in that tube. A raw result of 145 × 10⁹/L may look borderline until dilution correction gives approximately 160 × 10⁹/L. Also ask whether the laboratory used an optical or fluorescence platelet count, as these methods sometimes improve enumeration in complex samples.
Kantesti's 2026 interpretation workflow encourages users to compare the numerical result with the laboratory narrative and flag fields before acting on an alert. For a broader safety framework, our orodha ya ukaguzi ya usahihi ya ripoti ya AI covers transcription, units, reference ranges, and result verification.
What not to do while waiting for confirmation
Do not start supplements, stop prescribed medicines, or assume you have a bleeding disorder solely because one EDTA platelet count is low. At the same time, do not dismiss active bleeding just because clumping is suspected.
There is no diet, vitamin, or home remedy that corrects EDTA-dependent pseudothrombocytopenia because the platelets are clumping in the tube, not failing inside the body. Folate, vitamin B12, and iron deficiency can affect blood formation in other settings, but supplements cannot validate a questionable count. Treating the artifact is about collection and analysis.
Avoid non-essential aspirin, ibuprofen, naproxen, and heavy alcohol intake until a clinician has clarified a very low reported count, particularly if you bruise easily. Do not stop anticoagulants, antiplatelet medicines, antiseizure drugs, or cancer treatments without prescriber advice; the indication for those medicines may carry greater immediate risk than the unverified result.
Keeping a concise result timeline can change the appointment. Our lab result tracking guide suggests recording draw time, recent illness, medicines, sample comments, and whether the result came from EDTA or citrate.
Red flags that need urgent medical assessment
Seek urgent medical assessment for uncontrolled bleeding, black stools, vomiting blood, a severe new headache, confusion, fainting, or widespread pinpoint rash, even if EDTA clumping is suspected. A laboratory artifact and a genuine emergency can coexist.
A true platelet count below 10 × 10⁹/L is generally treated as an urgent result because spontaneous mucosal and internal bleeding risk rises substantially. A count below 20 × 10⁹/L with new bleeding, fever, severe hypertension, pregnancy complications, or recent heparin exposure also deserves same-day clinician input. Local emergency advice should take priority over any online interpretation.
New neurological symptoms are particularly significant because intracranial bleeding is uncommon but serious. Do not drive yourself if you have severe headache with weakness, speech change, collapse, or confusion. In children, a non-blanching rash with fever needs urgent assessment regardless of the platelet result.
Thomas Klein, MD, advises patients to separate the question “Is this count real?” from “Is this person safe today?” The first usually needs a smear and citrate redraw; the second depends on symptoms, exam findings, and the whole clinical picture. Our mwongozo wa maoni ya pili ya kipimo cha damu can help prepare a focused discussion after urgent issues are addressed.
How Kantesti interprets a flagged platelet count safely
Kantesti AI treats a low platelet count with EDTA clumping comments as a verification signal, not as proof of thrombocytopenia. Our interpretation places analyzer flags, the other CBC lines, prior values, and reported symptoms ahead of a simplistic red-or-green label.
Kantesti ni huduma ya kutafsiri vipimo vya maabara ya AI designed to explain laboratory data in plain language while preserving the limits of the source report. If an uploaded PDF states “platelet clumps,” our system should tell the user that the number may be falsely low and that the laboratory or clinician can confirm it with a film review or citrate sample.
Optical character recognition can misread a decimal point, a unit, or a laboratory footnote. That is why patients should inspect the image preview before relying on any digital interpretation, particularly around values such as 18 versus 180 × 10⁹/L. Our orodha ya ukaguzi ya ubora wa upakiaji wa PDF explains the few checks that prevent most avoidable errors.
Clinical oversight remains human work. Kantesti's methodology is reviewed against safety-focused workflows; readers who want to understand our approach can review our uthibitisho wa kiufundi na usimamizi wa kliniki. AI can organize questions efficiently, but it cannot inspect the actual smear or assess active bleeding.
A practical follow-up plan after EDTA platelet clumping
The usual follow-up plan is to document the EDTA artifact, obtain a verified alternative-tube platelet count, and use that result for future clinical decisions. Most people need no treatment for the artifact itself once the laboratory has established the pattern.
Ask for the laboratory record to note “EDTA-dependent platelet clumping” or equivalent wording if confirmation is clear. On future draws, the phlebotomy team may collect a citrate tube alongside the routine EDTA CBC, saving a second appointment. This is especially useful before surgery, during pregnancy, or when a treatment protocol has platelet thresholds.
A verified baseline is more valuable than repeated unverified low values. If your corrected citrate count is stable at 205 × 10⁹/L over 12 months, a future EDTA value of 55 × 10⁹/L with aggregates is far less alarming than the same number in someone without prior documentation. Trends are useful only when the testing method is comparable.
Kantesti has supported more than 2 million users across 127+ countries with multilingual laboratory explanations, but results still belong in the care relationship with your clinician. Our medical reviewers and Bodi ya Ushauri wa Matibabu emphasize the same final rule: verify the platelet count first, then decide what—if anything—needs treatment.
Machapisho ya utafiti
As of August 29, 2026, the two Kantesti research publications listed below are supplementary educational resources. They do not establish the diagnosis of EDTA-dependent pseudothrombocytopenia; the laboratory smear and alternative-anticoagulant platelet count remain the relevant confirmation tools.
Maswali Yanayoulizwa Mara Kwa Mara
Je, kuganda kwa chembechembe za damu kwa sababu ya EDTA kunaweza kusababisha kuhesabiwa kwa chembechembe za damu kuwa chini sana?
Ndiyo. Kufungamana kwa chembechembe za damu kwa kutumia EDTA kunaweza kusababisha hesabu ya chembechembe za damu kuwa ya chini sana, wakati mwingine chini ya 50 × 10⁹/L, wakati idadi halisi ya chembechembe za damu zinazozunguka mwilini ni ya kawaida. Kifaa cha uchunguzi hupunguza hesabu ya chembechembe za damu zilizoungana kwa sababu hakiwezi kutambua kwa uhakika kila chembechembe ndani ya kundi. Kipimo cha damu cha pembeni kinachoonyesha chembechembe zilizoungana na hesabu ya kawaida iliyorekebishwa ya citrate huunga mkono sana pseudothrombocytopenia. Matokeo yanapaswa kuchunguzwa kwa haraka ikiwa kuna kutokwa damu kwa kasi au ikiwa hesabu ya citrate inabaki chini.
Pseudothrombocytopenia inathibitishwa vipi?
Pseudothrombocytopenia kwa kawaida huthibitishwa kwa kukagua smear ya pembeni kwa mabonge ya chembechembe na kurudia hesabu ya chembechembe kwenye mirija ya sodiamu citrate. Mirija ya Citrate ina kiowevu cha kuzuia kuganda, kwa hivyo maabara nyingi huongeza hesabu ya chembechembe iliyopimwa kwa 1.1 ili kuzingatia upungufu. Kwa mfano, hesabu mbichi ya citrate ya 180 × 10⁹/L kwa kawaida huripotiwa kama takriban 198 × 10⁹/L baada ya kusahihishwa. Uthibitishaji wa kusahihisha na tafsiri ya smear ya maabara ya ndani unapaswa kuongoza matokeo ya mwisho.
Je, kuganda kwa vipande vya chembechembe katika EDTA kuna maana kuwa nina tatizo la kutoka damu?
Hakuna. Kuitana kwa vipande vya damu vya EDTA pekee ni kosa la sampuli ya nje ya mwili na haimaanishi kuwa una shida ya kutoka damu au kwamba vipande vyako vya damu vinaungana katika mzunguko wako wa damu. Watu wengi walioathirika hawana dalili za kutoka damu na wana idadi ya vipande vya damu iliyothibitishwa ndani ya kiwango cha kawaida cha watu wazima cha takriban 150-450 × 10⁹/L. Mtaalamu wa matibabu bado anapaswa kuchunguza dalili za kutoka damu, vipimo vya ugandishaji damu visivyo vya kawaida, au idadi ya vipande vya damu vya citrate ambayo iko chini kwa muda mrefu. Kosa hili la sampuli haliwezi kumlinda mtu dhidi ya hatari za kutoka damu ambazo hazihusiani na dawa au hali za kimatibabu.
Je, kuganda kwa chembe za damu kunaweza kutokea kwenye citrate pia?
Ndiyo, ingawa sodium citrate mara nyingi huzuia kuganda kwa EDTA, mkusanyiko wa chembe za damu unaweza kuendelea mara kwa mara katika citrate au kutokea na viini vingi. Katika hali hiyo, maabara inaweza kutumia hesabu ya chembe za damu kwa macho au kung'aa, uchakataji wa haraka wa joto, magnesium sulfate, au asidi-citrate-dextrose kulingana na itifaki zake zilizothibitishwa. Hesabu iliyosahihishwa ya citrate chini ya 150 × 10⁹/L bila makundi inapaswa kuchukuliwa kama uwezekano wa kweli wa thrombocytopenia. Kuganda kwa viini vingi haipatikani mara kwa mara na huhitaji uthibitisho unaoongozwa na maabara.
Should I repeat my platelet count if the report says platelet clumps?
Yes. A report that states platelet clumps, platelet aggregates, or an unreliable platelet count generally warrants verification rather than acceptance of the numerical result. The usual repeat is a freshly collected sodium citrate sample with a smear review, ideally processed promptly. If the original count is below 10 × 10⁹/L or you have uncontrolled bleeding, black stools, severe headache, or confusion, seek urgent medical care while the confirmation is arranged. Do not change prescribed medicine without advice from the clinician who knows why it was prescribed.
Can EDTA pseudothrombocytopenia come and go?
Yes. EDTA pseudothrombocytopenia can be persistent for years or appear variable because the degree of clumping depends on time after collection, sample temperature, and analyzer method. One EDTA sample may report 70 × 10⁹/L while another collected on a different day reports 145 × 10⁹/L, despite a stable true platelet count. A documented normal citrate count provides a useful baseline for future comparison. Asking the laboratory to record the preferred anticoagulant can prevent repeated false alarms.
Pata Uchambuzi wa Vipimo vya Damu kwa AI Leo
Jiunge na zaidi ya watumiaji 2 milioni duniani kote wanaoamini Kantesti kwa uchambuzi wa papo hapo na sahihi wa vipimo vya maabara. Pakia matokeo yako ya vipimo vya damu na upate tafsiri ya kina ya viashiria vya 15,000+ ndani ya sekunde.
📚 Machapisho ya Utafiti Yanayorejelewa
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti AI. (2026). C3 C4 Complement Blood Test & ANA Titer Guide. Zenodo. https://doi.org/10.5281/zenodo.18353989. Kantesti uchambuzi wa damu kwa AI ya utafiti wa matibabu.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti AI. (2026). Nipah Virus Blood Test: Early Detection & Diagnosis Guide 2026. Zenodo. https://doi.org/10.5281/zenodo.18487418. Kantesti uchambuzi wa damu kwa AI ya utafiti wa matibabu.
📖 Marejeo ya Nje ya Tiba
⚕️ Kanusho la Kimatibabu
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Uzoefu
Mapitio ya kimatibabu inayoongozwa na daktari ya mifumo ya tafsiri ya maabara.
Utaalamu
Kuzingatia dawa za maabara kuhusu jinsi viashiria (biomarkers) vinavyobadilika katika muktadha wa kliniki.
Mamlaka
Imeandikwa na Dk. Thomas Klein kwa mapitio ya Dk. Sarah Mitchell na Prof. Dk. Hans Weber.
Uaminifu
Tafsiri inayotegemea ushahidi yenye njia zilizo wazi za ufuatiliaji ili kupunguza tahadhari za hofu.